Technology area: Biotechnology & Pharmaceuticals
29 pending office actions • 12 art units • 24 examiners • 0 of 29 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days
Singular Genomics Systems Inc. has 28 pending office actions in Biotechnology & Pharmaceuticals. The matters span 24 distinct examiners and 12 distinct art units, indicating broad examiner coverage with more recurring technical-group assignments.
LU, FRANK WEI MIN is the busiest examiner, with 3 pending matters. That concentration provides a useful point for targeted examiner review, but it does not account for the majority of the portfolio’s examination relationships.
The examiner count being twice the art-unit count shows that multiple examiners are active within at least some technical groupings. Counsel should track both art-unit trends and individual examiner practices when coordinating biotechnology claim language, written-description positions, and prior-art responses.
A portfolio-level process can support consistent scientific disclosures and related-application strategy. Matter-specific preparation remains necessary because the profile combines repeated art-unit settings with a wide range of examiners.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (21%) |
| §112 only | 4 (14%) |
| Double-patenting + other | 3 (10%) |
| Multi-statute (no §101) | 16 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LU, FRANK WEI MIN | 3 | 62.7% | +67.9% |
| CROW, ROBERT THOMAS | 2 | 41.6% | +32.5% |
| YU, TIAN NMN | 2 | 55.6% | +19.3% |
| KIM, YOUNG J | 2 | 64.8% | +18.2% |
| QIAN, CELINE X | 1 | 47.5% | +17.2% |
| ELHILO, EISA B | 1 | 82.9% | +16.2% |
| TANINGCO, MARCUS H | 1 | 81.0% | +6.6% |
| HAQ, SHAFIQUL | 1 | 64.8% | +55.2% |
| SISSON, BRADLEY L | 1 | 19.7% | +20.5% |
| WILDER, CYNTHIA B | 1 | 70.8% | +27.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18050688 | METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING | CROW, ROBERT THOMAS | 97d overdue |
| 18364849 | COMPETITIVE METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES | TURPIN, ZACHARY MARK | 8d overdue |
| 17938254 | Polynucleotide Barcodes for Multiplexed Proteomics | BUNKER, AMY M | 4d overdue |
| 18915941 | PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS | SISSON, BRADLEY L | 13d |
| 18537266 | CONTROLLED ROLLING CIRCLE AMPLIFICATION | KIM, YOUNG J | 27d |
| 18309128 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | JOHANNSEN, DIANA B | 34d |
| 19564081 | DETECTION OF ANALYTES IN CELLS AND TISSUES | CROW, ROBERT THOMAS | — |
| 19345390 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | QIAN, CELINE X | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18050688 | METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING | CROW, ROBERT THOMAS | 97d overdue |
| 18915941 | PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS | SISSON, BRADLEY L | 13d |
| 18537266 | CONTROLLED ROLLING CIRCLE AMPLIFICATION | KIM, YOUNG J | 27d |
| 19564081 | DETECTION OF ANALYTES IN CELLS AND TISSUES | CROW, ROBERT THOMAS | — |
| 19345390 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | QIAN, CELINE X | — |
| 19344246 | METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING | LU, FRANK WEI MIN | — |
| 19228533 | RHODAMINE FLUORESCENT COMPOUNDS AND METHODS OF USE THEREOF | ELHILO, EISA B | — |
| 18959243 | ANALYZING CELL SAMPLES | HAQ, SHAFIQUL | — |
| Art Unit | Apps |
|---|---|
| 1681 | 10 |
| 1682 | 6 |
| 1683 | 4 |
| 1637 | 1 |
| 1761 | 1 |
| 2884 | 1 |
| 1678 | 1 |
| 1797 | 1 |
| 1693 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19564081 | DETECTION OF ANALYTES IN CELLS AND TISSUES | CROW, ROBERT THOMAS | 1683 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2026 |
| 19345390 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | QIAN, CELINE X | 1637 | §103§112Other | Final Rejection | — | Pending | Sep 30, 2025 |
| 19344246 | METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | — | Pending | Sep 29, 2025 |
| 19228533 | RHODAMINE FLUORESCENT COMPOUNDS AND METHODS OF USE THEREOF | ELHILO, EISA B | 1761 | §102§112 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19039258 | SYSTEMS AND METHODS FOR MULTICOLOR IMAGING | TANINGCO, MARCUS H | 2884 | §102§103§112Other | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18959243 | ANALYZING CELL SAMPLES | HAQ, SHAFIQUL | 1678 | §103§112 | Final Rejection | — | Pending | Nov 25, 2024 |
| 18915941 | PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS | SISSON, BRADLEY L | 1682 | §112 | Non-Final OA | 13d | Pending | Oct 15, 2024 |
| 18812056 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | WILDER, CYNTHIA B | 1681 | §112DP | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18797131 | SPATIAL DETECTION OF CLONOTYPES IN TISSUES | MUMMERT, STEPHANIE KANE | 1681 | §102§103 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18797267 | METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING | RILEY, JEZIA | 1681 | §103§112 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18679036 | PHOTOSTABLE DETECTABLE COMPOUNDS | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | May 30, 2024 |
| 18704416 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | YU, TIAN NMN | 1681 | §102§103§112 | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18592127 | METHODS FOR DIFFERENTIATING MODIFIED NUCLEOBASES | PRIEST, AARON A | 1681 | §103 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18390463 | TARGETING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF | KIM, YOUNG J | 1681 | §103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18543979 | DISULFIDE CONTAINING THERAPEUTICS | GALSTER, SAMUEL LEONARD | 1693 | §103 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18537540 | LINKED TRANSCRIPT SEQUENCING | GOLDBERG, JEANINE ANNE | 1682 | §103DP | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18537266 | CONTROLLED ROLLING CIRCLE AMPLIFICATION | KIM, YOUNG J | 1681 | §102§103§112 | Final Rejection | 27d | Pending | Dec 12, 2023 |
| 18507761 | AMPLIFICATION OLIGONUCLEOTIDES | GREENE, CAROLYN LEE | 1681 | §103§112 | Final Rejection | — | Pending | Nov 13, 2023 |
| 18490491 | MULTI-DIMENSIONAL POLYMER SCAFFOLDS FOR NUCLEIC ACID ANALYSES | WHATLEY, BENJAMIN R | 1699 | §102§103§112DP | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18365476 | TETHERED DETECTION ASSAYS | EVANS, CHRISTOPHER RYAN | 1677 | §102§103§112 | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18364849 | COMPETITIVE METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES | TURPIN, ZACHARY MARK | 1682 | §103§112 | Final Rejection | 8d overdue | Pending | Aug 03, 2023 |
| 18309128 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | JOHANNSEN, DIANA B | 1682 | §102§103§112 | Non-Final OA | 34d | Pending | Apr 28, 2023 |
| 18303468 | TARGETED SEQUENCING | HORLICK, KENNETH R | 1681 | §103 | Final Rejection | — | Pending | Apr 19, 2023 |
| 18069990 | STRAND DISPLACING SEQUENCING ENZYMES | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | — | Pending | Dec 21, 2022 |
| 18069078 | PHASE PROTECTIVE REAGENT FLOW ORDERING | KENNEDY, SARAH JANE | 1682 | §103 | Final Rejection | — | Pending | Dec 20, 2022 |
| 18050688 | METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING | CROW, ROBERT THOMAS | 1682 | §103§112 | Non-Final OA | 97d overdue | Pending | Oct 28, 2022 |
| 17938329 | METHODS FOR IN SITU PROTEOMICS | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | — | Pending | Oct 05, 2022 |
| 17938254 | Polynucleotide Barcodes for Multiplexed Proteomics | BUNKER, AMY M | 1684 | §102§103 | Final Rejection | 4d overdue | Pending | Oct 05, 2022 |
| 17531488 | CONTACTLESS DETECTION OF AN ABERRANT CONDITION | YU, TIAN NMN | 1681 | §103 | Non-Final OA | — | Pending | Nov 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSingular Genomics Systems Inc. has 29 pending office actions as of October 2026, spread across 12 art units and 24 examiners.
Frank Wei Min Lu has the most, with 3 of Singular Genomics Systems Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
